Hudson Bay Capital Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.35M Buy
+20,010
New +$4.44M 0.02% 556
2025
Q4
Sell
-69,352
Closed -$16.1M 1161
2025
Q3
$16.1M Sell
69,352
-36,434
-34% -$7.42M 0.05% 263
2025
Q2
$19.6M Sell
105,786
-545,085
-84% -$101M 0.07% 216
2025
Q1
$136M Buy
650,871
+620,768
+2,062% +$121M 0.42% 53
2024
Q4
$5.35M Sell
30,103
-44,897
-60% -$8.25M 0.02% 490
2024
Q3
$14.8M Buy
75,000
+45,000
+150% +$8.4M 0.06% 207
2024
Q2
$5.15M Buy
+30,000
New +$4.97M 0.02% 366
2023
Q4
Sell
-210,552
Closed -$31.4M 704
2023
Q3
$31.4M Sell
210,552
-120,000
-36% -$17.6M 0.25% 69
2023
Q2
$44.5M Buy
330,552
+222,552
+206% +$32.6M 0.32% 75
2023
Q1
$17.2M Buy
108,000
+82,000
+315% +$12.5M 0.14% 110
2022
Q4
$4.2M Sell
26,000
-174,000
-87% -$26.7M 0.04% 403
2022
Q3
$26.8M Buy
+200,000
New +$28.7M 0.24% 60
2019
Q3
Sell
-15,000
Closed -$1.09M 394
2019
Q2
$1.09M Buy
+15,000
New +$1.18M 0.03% 324
2017
Q2
Sell
-11,528
Closed -$751K 513
2017
Q1
$751K Buy
+11,528
New +$725K 0.01% 667
2014
Q4
Sell
-152,364
Closed -$8.8M 180
2014
Q3
$8.8M Buy
+152,364
New +$8.46M 0.25% 78

Other funds holding ABBV

Hudson Bay Capital Management's ABBV Position: Q1 2026 in Review

Hudson Bay Capital Management opened a new position in AbbVie (ABBV) in Q1 2026: 20,010 shares worth $4.35M. The stake represents 0.02% of the portfolio and ranks #556 among its holdings. This is a return to the name: Hudson Bay Capital Management previously reported a position in ABBV as recently as Q3 2025.

Hudson Bay Capital Management first reported a position in ABBV in Q3 2014 and has held it in 15 quarters since. The position peaked at $136M in Q1 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Hudson Bay Capital Management held 20,010 shares of AbbVie worth $4.35M as of Q1 2026.
  • AbbVie was a new Hudson Bay Capital Management position in Q1 2026.
  • AbbVie made up 0.02% of Hudson Bay Capital Management's portfolio in Q1 2026, its #556 holding.
  • Hudson Bay Capital Management first reported a position in AbbVie in Q3 2014 and has held it in 15 quarters since.
  • Hudson Bay Capital Management's AbbVie position peaked at $136M in Q1 2025.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Hudson Bay Capital Management's 13F filing for Q1 2026, filed 13 May 2026.